In junctional biliary tract cancer, invasion depth may stage prognosis better than anatomy alone.
@gastroagi.bsky.social
@gastroagi.bsky.socialIn junctional biliary tract cancer, invasion depth may stage prognosis better than anatomy alone.
@charityammf.bsky.socialWhat causes cholangiocarcinoma?
In most cases, the exact cause of #cholangiocarcinoma (#CCA or #bileductcancer) is unknown. Many cases are sporadic, meaning they occur without a clear reason.
To read more please visit AMMF’s website https://ammf.org.uk/causes-and-risk-factors/
@digestivecancerseu.bsky.social#Cholangiocarcinoma 🇮🇪 has joined DiCE, bringing lived experience, patient advocacy, & a strong rare-cancer perspective.
Together, we will raise awareness, strengthen patient voices & improve support for people affected by cholangiocarcinoma.
@egastroenterology.bsky.social📢 New in #eGastroenterology: TERT rs10069690 shows contrasting links to cholangiocarcinoma.
🧬 Lower intrahepatic CCA risk
📉 Shorter survival after resection
🛡️ Links to immune and proliferation signatures
@charityammf.bsky.social💜 Stay warm and show your support 💜
If you're out fundraising, walking the dog or just out and about, it’s a great way to keep warm, and can be a great conversation starter about #CCA and #AMMF too!
Buy yours here: https://ammf.org.uk/product/beanie-hat/
#bileductcancer #Cholangiocarcinoma
@charityammf.bsky.socialAMMF are advocating for the Cholangiocarcinoma patients and continuing our campaign to ‘Reth!nk Liver Cancer’ at the Big Cancer52 Conversation in London💜📢🙌
@charityammf.bsky.social#Cholangiocarcinoma, or #bileductcancer, is a primary liver cancer which starts in the inside lining of the ducts of the biliary tree; this is a network of tubes that carry bile from the liver to the gut.
To find out more visit: https://ammf.org.uk/about-cholangiocarcinoma/
@charityammf.bsky.social💜 🍂Feeling the autumn chill this October? 🍂💜
Help raise awareness of #cholangiocarcinoma wherever you go and order your AMMF hoodie here: https://ammf.org.uk/product/hoodie/
@charityammf.bsky.social💜October is Liver Cancer Awareness Month 💜
#Cholangiocarcinoma is a primary liver cancer! Once considered rare, this is no longer the case.
It’s time to Reth!nk Liver Cancer.
We'll be raising awareness and sharing information about #CCA throughout the month.
@fabermdphd.bsky.socialWe need more of this type of work looking at differences between primary lesion and intrahepatic metastases in understudied #cholangiocarcinoma for development of better #TME targeting treatments
@liversmdpi.bsky.social📢 New Review in #LiversMDPI
🧬 Digital and biological twins in cholangiocarcinoma
🩺 Fully realized medical digital twins remain unavailable, while biological twins face scalability and standardization challenges.
📖 Read More: www.mdpi.com/2673-4389/6/...
#PrecisionOncology #Cholangiocarcinoma
@targetedonc.bsky.social📢 ICYMI: The #FDA has approved lirafugratinib (Lyrfigtu) for adults with previously treated unresectable, locally advanced or metastatic #cholangiocarcinoma harboring an FGFR2 gene fusion or other rearrangement.
Read more: targetedonc.com/view/fda-app...
@duboisrn.bsky.socialFDA Approves #Lirafugratinib for Previously Treated #FGFR2-Altered #Cholangiocarcinoma: www.pharmacytimes.com/view/fda-app...
@oncoalert.bsky.socialFDA News: REFOCUS Update in #Cholangiocarcinoma
On September 23, 2026, the FDA🇺🇸 approved lirafugratinib for adults with previously treated, unresectable, locally advanced or metastatic cholangiocarcinoma harboring FGFR2🧬 fusions or rearrangements.
@charityammf.bsky.socialNot sure what support is available to you? #AMMF has a host of helpful links available of external resources which are focused on helping anyone affected by #cholangiocarcinoma.
Remember, support is always available and AMMF are always here 💜
@genesndiseases.bsky.socialPrecision medicine is transforming #cholangiocarcinoma care.
This review highlights advances in targeted therapies and #immunotherapy while addressing challenges such as drug resistance and biomarker discovery. #TumorMicroenvironment
#GenesAndDiseases: doi.org/10.1016/j.ge...
@charityammf.bsky.social#AMMF Palliative Care Webinar
Where we will be dispelling the myths and understanding the facts of palliative care.
📅 Wednesday 23 September 2026
⏰ 6pm – 7:30pm
🔗 https://us02web.zoom.us/webinar/register/WN_aIqza-pVQMmA7dfSNouZAw
@charityammf.bsky.social🔬AMMF Funded Research🔬
Head over to #AMMF’s Facebook to hear about Arezoo Ghodsifard’s research on ‘Artificial Intelligence as a Biomarker for Intrahepatic #Cholangiocarcinoma’.
@charityammf.bsky.social🔬AMMF Funded Research🔬
Head over to #AMMF’s Facebook to hear about Professor Shijie Cai’s Research on ‘Unleashing the power of normal cholangiocytes to counteract #cholangiocarcinoma’.